ARCHIVES

Sharfstein To Leave FDA

This article is from The Cancer Letter archive.

Vol. 37 No. 01 | January 7, 2011

Download PDF Visit The Full Archive

Related Articles

NHLBI Advisers Commit Funding TO NCI’s Women’s Health Trials, Tamoxifen Trial

March 8, 1991

Boyd’s Rebuttal to DePinho’s Letter to the AAUP

May 30, 2014

Markup Of Cancer Act Renewal Set For Mid-October

September 21, 1979

ACC Survey Preliminary Finding: Three Cancer DRG Categories “Clearly Underpaid Across The Board”

January 25, 1985

New Drugs Improve Outlook For Bone Marrow Cancer

March 31, 2006

New Recommendations made For Radiation Protection Standards

August 14, 1987